Subscribe To
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference
WILMINGTON, Del. and BOSTON, Oct. 14, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (“Prelude”) (Nasdaq: PRLD), a clinical-stage precision oncology company, announces multiple clinical and preclinical posters at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, known as the Triple Meeting, from October 11 – 15, 2023 at the Hynes Convesntion Center in Boston, MA. The […] The post Prelude Announces Multiple Clinical and Preclinical Poster Present...
Read More
Posted: Oct 14 2023, 16:30
Author Name: forextv
Views: 112461